Roche Holding AG Participation (ROG)

331.45
+6.95(+2.14%)
  • Volume:
    1,438,092
  • Bid/Ask:
    331.40/331.45
  • Day's Range:
    322.35 - 332.60
  • Type:Equity
  • Market:Switzerland
  • ISIN:CH0012032048
  • S/N:1203204

ROG Overview

Prev. Close
324.5
Day's Range
322.35-332.6
Revenue
62.8B
Open
323.5
52 wk Range
308.9-404.15
EPS
16.19
Volume
1,438,092
Market Cap
270.03B
Dividend (Yield)
9.30
(2.81%)
Average Volume (3m)
1,531,708
P/E Ratio
20.04
Beta
0.95
1-Year Change
4.41%
Shares Outstanding
800,403,291
Next Earnings Date
20 Jul 2022
What is your sentiment on Roche Holding Participation?
or
Market is currently closed. Voting is open during market hours.

Roche Holding AG Participation News

Roche Holding AG Participation Analysis

Roche Holding AG Participation Company Profile

Roche Holding AG Participation Company Profile

Employees
100920

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuySellNeutral
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyStrong BuyStrong SellNeutral